NexgenRx Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
May 17, 2022 at 05:03 pm EDT
NexgenRx Inc. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported revenue was CAD 3.17 million compared to CAD 2.8 million a year ago. Net income was CAD 0.377956 million compared to CAD 0.362111 million a year ago. Basic earnings per share from continuing operations was CAD 0.005 compared to CAD 0.005 a year ago. Diluted earnings per share from continuing operations was CAD 0.005 compared to CAD 0.005 a year ago.